cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.kjftgj
title: Occurrence Download

description: A dataset containing 1164 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON((-103.43779 20.74392,-103.40729 20.74392,-103.40729 20.76694,-103.43779 20.76694,-103.43779 20.74392))",
 "OccurrenceStatus is Present"
 ]
}

 The dataset includes 1164 records from 30 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0050422-250827131500795/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.srxr3x
title: Occurrence Download

description: A dataset containing 14 species occurrences available in GBIF matching the query:
{
 "and" : [
 "GadmGid is COL.28.82_2",
 "OccurrenceStatus is Present",
 "TaxonKey is Mammalia"
 ]
}

 The dataset includes 14 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0050419-250827131500795/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.17094809
title: All Countries' Dataset
DOI: 10.5281/zenodo.17094810
title: All Countries' Dataset
DOI: 10.15468/dl.ffwgvk
title: Occurrence Download

description: A dataset containing 4 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "TaxonKey is Sesarmoides longipes"
 ]
}

 The dataset includes 4 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0050424-250827131500795/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.71819/od3dzm
title: ENGIE | Fauna Monitoring of the Serra do Assuruá Wind Complex – Amphibians

description: Amphibian data collected as part of the Fauna Monitoring Program during the implementation of the Serra do Assuruá Wind Farm Complex, located in the rural area of the municipality of Gentio do Ouro, Bahia (BA).
DOI: 10.15468/dl.8f6ehu
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "ScientificName" : [
 "is Acacia schweinfurthii"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0050337-250827131500795/datasets/export for details.
DOI: 10.15468/dl.qxdamv
title: Occurrence Download

description: A dataset containing 24 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Abramis brama",
 "HasCoordinate is true",
 "Country is Ireland"
 ]
}

 The dataset includes 24 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0050427-250827131500795/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.aruz5d
title: Occurrence Download

description: A dataset containing 10757 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Abramis brama",
 "HasCoordinate is true",
 "Country is United Kingdom of Great Britain and Northern Ireland"
 ]
}

 The dataset includes 10757 records from 42 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0050426-250827131500795/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.34740/kaggle/dsv/13021100
title: Highest Grossing Indian Films by region-language
DOI: 10.15468/dl.skpvdt
title: Occurrence Download

description: A dataset containing 45505 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Abramis brama",
 "HasCoordinate is true",
 "Country is France"
 ]
}

 The dataset includes 45505 records from 200 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0050428-250827131500795/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.u556j3
title: Occurrence Download

description: A dataset containing 4360 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Colombia",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Jacaranda copaia"
 ]
}

 The dataset includes 4360 records from 127 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0050431-250827131500795/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.u9fynt
title: Occurrence Download

description: A dataset containing 5294 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Roseodendron chryseum",
 "HasCoordinate is true"
 ]
}

 The dataset includes 5294 records from 44 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0050430-250827131500795/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.wfcapj
title: Occurrence Download

description: A dataset containing 2667 species occurrences available in GBIF matching the query:
{
 "DatasetKey" : [
 "is PINK - Dragonfly (Odonata) monitoring for the permanent surveillance of coastal areas in Flanders, Belgium"
 ]
}

 The dataset includes 2667 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0050429-250827131500795/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.17632/d5jd4st94k
title: Supplemental Material for Efficacy of Phototherapy in Managing Cutaneous Immune-Related Adverse Events in Patients Treated with Checkpoint Inhibitors

description: Supplemental material for Efficacy of Phototherapy in Managing Cutaneous Immune-Related Adverse Events in Patients Treated with Checkpoint Inhibitors
DOI: 10.17632/d5jd4st94k.1
title: Supplemental Material for Efficacy of Phototherapy in Managing Cutaneous Immune-Related Adverse Events in Patients Treated with Checkpoint Inhibitors

description: Supplemental material for Efficacy of Phototherapy in Managing Cutaneous Immune-Related Adverse Events in Patients Treated with Checkpoint Inhibitors
DOI: 10.17632/k628y7s96s
title: Fatal infection of a novel canine/human reassortant H3N2 influenza A virus in the zoo-housed golden monkeys

description: In June 2022, seven golden monkeys (Rhinopithecus roxellana) developed flu-like symptoms in succession at a zoo in Jiangsu Province, China, and two died of respiratory distress. Histopathological and immunostaining results supported a diagnosis of pulmonary infection with influenza virus. An H3N2 canine/human reassortment virus, designated A/golden monkey/Jiangsu/1/2022 (Gm-1), was isolated from the lungs of deceased animals. Sequencing analysis revealed that except for PB1 gene that was 99% similar to that from human H1N1 virus (A/WSN/1933, WSN), the other 7 segments of Gm-1 were entirely derived from previously circulating canine H3N2 virus (A/canine/Jiangsu/06/2010, JS06). To determine whether the human-origin PB1 segment conferred a virulence advantage to Gm-1, we reconstructed this reassortant event using reverse genetics and generated two reassortment viruses, rGm-1 and rJS06. Experimental infection of mice revealed that the rGm-1 virus induced more severe pathological damage along with higher levels of proinflammatory cytokines in the lungs, suggesting that replacement of the PB1 segment of JS06 by PB1 of WSN enhanced viral virulence. Furthermore, we identified a unique cytotoxic motif (68I, 69L and 70V) in PB1-F2 protein that was present in Gm-1 but absent in JS06, potentially enhancing viral virulence. This is the first report confirming IAV infection in golden monkeys. Our finding highlight the the importance of enhanced biosecurity surveillance for this endangered species.
DOI: 10.17632/k628y7s96s.2
title: Fatal infection of a novel canine/human reassortant H3N2 influenza A virus in the zoo-housed golden monkeys

description: In June 2022, seven golden monkeys (Rhinopithecus roxellana) developed flu-like symptoms in succession at a zoo in Jiangsu Province, China, and two died of respiratory distress. Histopathological and immunostaining results supported a diagnosis of pulmonary infection with influenza virus. An H3N2 canine/human reassortment virus, designated A/golden monkey/Jiangsu/1/2022 (Gm-1), was isolated from the lungs of deceased animals. Sequencing analysis revealed that except for PB1 gene that was 99% similar to that from human H1N1 virus (A/WSN/1933, WSN), the other 7 segments of Gm-1 were entirely derived from previously circulating canine H3N2 virus (A/canine/Jiangsu/06/2010, JS06). To determine whether the human-origin PB1 segment conferred a virulence advantage to Gm-1, we reconstructed this reassortant event using reverse genetics and generated two reassortment viruses, rGm-1 and rJS06. Experimental infection of mice revealed that the rGm-1 virus induced more severe pathological damage along with higher levels of proinflammatory cytokines in the lungs, suggesting that replacement of the PB1 segment of JS06 by PB1 of WSN enhanced viral virulence. Furthermore, we identified a unique cytotoxic motif (68I, 69L and 70V) in PB1-F2 protein that was present in Gm-1 but absent in JS06, potentially enhancing viral virulence. This is the first report confirming IAV infection in golden monkeys. Our finding highlight the the importance of enhanced biosecurity surveillance for this endangered species.
DOI: 10.17632/357g6dt48v
title: A 48-week real-world outcome of tralokinumab treatment for atopic dermatitis: Systemic therapy-naïve versus -experienced patients

description: Supplementary Figure 1. The transition of eczema area and severity index (EASI) on four anatomical sites in patients with atopic dermatitis treated with tralokinumab. EASI scores on head and neck, trunk, upper limbs, or lower limbs are shown as means of systemic therapy–naïve patients (n = 92, green) or systemic therapy–experienced patients (n = 84, purple) during the 48-week treatment. All indices from week 4 through week 48 were significantly lower than baseline values in each group (p &lt; 0.01 by repeated-measures ANOVA with Bonferroni correction). *p &lt; 0.05, **p &lt; 0.01, versus value of systemic therapy–experienced patients at each time-point, by Student’s t-test.

Supplementary Figure 2. Achievement rates of eczema area and severity index (EASI) 50, EASI 75, EASI 90, EASI 100, and investigator’s global assessment (IGA) 0/1 in patients with atopic dermatitis treated with tralokinumab. Data are shown as percentages for systemic therapy–naïve patients (n = 92, green) or systemic therapy–experienced patients (n = 84, purple) during the 48-week treatment. *p &lt; 0.05, **p &lt; 0.01, versus value of systemic therapy–experienced patients at each time-point, by Fisher’s exact test.

Supplementary Figure 3. Achievement rates of peak pruritus numerical rating scale (PP-NRS) 4 and atopic dermatitis control tool (ADCT) 7 in patients with atopic dermatitis treated with tralokinumab. Data are shown as percentages for systemic therapy–naïve patients (n = 92, green) or systemic therapy–experienced patients (n = 84, purple) during the 48-week treatment. *p &lt; 0.05, **p &lt; 0.01, versus value of systemic therapy–experienced patients at each time-point, by Fisher’s exact test.

Supplementary Figure 4. The transition of laboratory indexes in patients with atopic dermatitis treated with tralokinumab. Serum IgE, thymus and activation-regulated chemokine (TARC), lactate dehydrogenase (LDH), and total eosinophil count (TEC) are shown as medians for systemic therapy–naïve patients (n = 92, green) or systemic therapy–experienced patients (n = 84, purple) during the 48-week treatment. 
*p &lt; 0.05, ** p &lt; 0.01, versus value of systemic therapy–experienced patients at each time-point, by Mann–Whitney U test.
Friedman's test with Bonferroni’ s correction detected significant differences from baseline values at following time-periods in each group:
1. IgE: weeks 12–48 (p &lt; 0.01) in systemic therapy–naïve group and week 4 (p &lt; 0.05) and weeks 12–48 (p &lt; 0.01) in systemic therapy–experienced group.
2. TARC: weeks 4–48 (p &lt; 0.01) in both groups. 
3. LDH: week 24 (p &lt; 0.05) and weeks 36 and 48 (p &lt; 0.01) in systemic therapy-naïve group and weeks 4, 12 and 24 (p &lt; 0.01), week 36 (p &lt; 0.05) and week 48 (p &lt; 0.01) in systemic therapy–experienced group.
4. TEC: no significant differences in either group
DOI: 10.17632/357g6dt48v.1
title: A 48-week real-world outcome of tralokinumab treatment for atopic dermatitis: Systemic therapy-naïve versus -experienced patients

description: Supplementary Figure 1. The transition of eczema area and severity index (EASI) on four anatomical sites in patients with atopic dermatitis treated with tralokinumab. EASI scores on head and neck, trunk, upper limbs, or lower limbs are shown as means of systemic therapy–naïve patients (n = 92, green) or systemic therapy–experienced patients (n = 84, purple) during the 48-week treatment. All indices from week 4 through week 48 were significantly lower than baseline values in each group (p &lt; 0.01 by repeated-measures ANOVA with Bonferroni correction). *p &lt; 0.05, **p &lt; 0.01, versus value of systemic therapy–experienced patients at each time-point, by Student’s t-test.

Supplementary Figure 2. Achievement rates of eczema area and severity index (EASI) 50, EASI 75, EASI 90, EASI 100, and investigator’s global assessment (IGA) 0/1 in patients with atopic dermatitis treated with tralokinumab. Data are shown as percentages for systemic therapy–naïve patients (n = 92, green) or systemic therapy–experienced patients (n = 84, purple) during the 48-week treatment. *p &lt; 0.05, **p &lt; 0.01, versus value of systemic therapy–experienced patients at each time-point, by Fisher’s exact test.

Supplementary Figure 3. Achievement rates of peak pruritus numerical rating scale (PP-NRS) 4 and atopic dermatitis control tool (ADCT) 7 in patients with atopic dermatitis treated with tralokinumab. Data are shown as percentages for systemic therapy–naïve patients (n = 92, green) or systemic therapy–experienced patients (n = 84, purple) during the 48-week treatment. *p &lt; 0.05, **p &lt; 0.01, versus value of systemic therapy–experienced patients at each time-point, by Fisher’s exact test.

Supplementary Figure 4. The transition of laboratory indexes in patients with atopic dermatitis treated with tralokinumab. Serum IgE, thymus and activation-regulated chemokine (TARC), lactate dehydrogenase (LDH), and total eosinophil count (TEC) are shown as medians for systemic therapy–naïve patients (n = 92, green) or systemic therapy–experienced patients (n = 84, purple) during the 48-week treatment. 
*p &lt; 0.05, ** p &lt; 0.01, versus value of systemic therapy–experienced patients at each time-point, by Mann–Whitney U test.
Friedman's test with Bonferroni’ s correction detected significant differences from baseline values at following time-periods in each group:
1. IgE: weeks 12–48 (p &lt; 0.01) in systemic therapy–naïve group and week 4 (p &lt; 0.05) and weeks 12–48 (p &lt; 0.01) in systemic therapy–experienced group.
2. TARC: weeks 4–48 (p &lt; 0.01) in both groups. 
3. LDH: week 24 (p &lt; 0.05) and weeks 36 and 48 (p &lt; 0.01) in systemic therapy-naïve group and weeks 4, 12 and 24 (p &lt; 0.01), week 36 (p &lt; 0.05) and week 48 (p &lt; 0.01) in systemic therapy–experienced group.
4. TEC: no significant differences in either group
DOI: 10.17632/h8mj9zgts9
title: Replication repository for “Credit and firm organization”

description: This repository contains the readme file and the codes to replicate the results in the paper “Credit and firm organization”, by A. Sforza and E. M. Acabbi. Please note that data are confidential and access has to be granted by the Bank of Portugal upon request. More instruction on data access can be found in the read me file.
DOI: 10.17632/h8mj9zgts9.1
title: Replication repository for “Credit and firm organization”

description: This repository contains the readme file and the codes to replicate the results in the paper “Credit and firm organization”, by A. Sforza and E. M. Acabbi. Please note that data are confidential and access has to be granted by the Bank of Portugal upon request. More instruction on data access can be found in the read me file.
DOI: 10.17632/fzdfcktzvr
title: Coniferous leaf litter enhances soil carbon stabilization despite slower decomposition than broadleaf litter in subtropical forests

description: Despite lower mass loss than broadleaf litter, evergreen coniferous litter contributed more to SOC accumulation.
DOI: 10.17632/fzdfcktzvr.1
title: Coniferous leaf litter enhances soil carbon stabilization despite slower decomposition than broadleaf litter in subtropical forests

description: Despite lower mass loss than broadleaf litter, evergreen coniferous litter contributed more to SOC accumulation.
DOI: 10.7910/dvn/yl9jj0
title: Replication data for: "Skewness Risk Premia and the Cross-Section of Currency Returns".

description: Data and codes for "Skewness Risk Premia and the Cross-Section of Currency Returns," accepted at JFQA.
DOI: 10.15468/dl.9pszgc
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Spiraea prunifolia",
 "Country is Austria",
 "HasCoordinate is true"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0050436-250827131500795/datasets/export for details.
DOI: 10.5281/zenodo.16914232
title: Optimized PM2.5 Source Profiles using CMAQ-ISAM and an updated seed profile incorporating California onroad mobile measurements

description: This dataset is a collection of optimized, chemically speciated PM2.5 source profiles for 5 sites in California over the month of January 2016. The sites are listed below:






Site Name



State



AQS Site ID



Latitude



Longitude





Bakersfield



CA



06-029-0014



35.356092



-119.041209





Fresno



CA



06-019-0011



36.785322



-119.774174





Modesto



CA



06-099-0005



37.642165



-120.9942120





Sacramento



CA



06-067-0006



38.613779



-121.368014





Visalia



CA



06-107-2002



36.332179



-119.291228





All profiles used the same nonlinear optimization process as explained in Ivey et al. 2016, (doi.org/10.1007/s11783-016-0866-6) with the addition of two source sectors that incorporate aging of initial emissions into PM2.5. The sensitivity inputs for these profiles are 24-hour averaged CMAQ-ISAM data corresponding to the dates of CSN measurements collected at the five sites. All profiles use chemical speciation network (CSN) measurements collected over January 2016 at the sites in question as the observational component. The site and day-specific CMAQ-ISAM data can be found at https://doi.org/10.5281/zenodo.16914295.

The "seed profile" used in the optimization process is also available in this dataset as "California_SeedProfile.csv" and uses speciated emissions data from Reff et al., (doi.org/10.1021/es802930x) as well as aged source impacts derived from CMAQ-DDM for AG (doi.org/10.1007/s11783-016-0866-6) and observations of organic nitrate and organosulfate molecular weights for BIO (doi.org/10.5194/acp-15-7307-2015). The profiles for on- and non-road diesel and gasoline emissions (ODE, OGA, NDE, and NGA) were updated using California-specific observations for onroad gasoline and diesel PM2.5 emissions accessed with EPA SPECIATE v5.3. The optimized profiles are provided without row or column labels, but this information can be found in the seed profile file. One profile file is uploaded for each day of available CSN observations at each of the five sites.

The optimized profiles are normalized by source (i.e., the sum of all species contributions for one source must equal 1), and the units in the profile are grams of speciated PM2.5/gram of total PM2.5 from the source. The source categories used here are:






Category name



Description of included sources





AG



Agricultural activities and livestock operations





AIR



Aircraft operations





BIO



Biogenics





COA



Coal combustion





DUS



Dust





FOI



Fuel oil combustion





MET



Metals processing





NDE



Non-road diesel combustion





NG



Natural gas combustion





NGA



Non-road gasoline





NRO



Non-road combustion of other fuels





ODE



On-road diesel combustion





OGA



On-road gasoline combustion





ORO



On-road combustion of other fuels





OTH



All other sources





RAL



Rail operations





RWC



Residential wood combustion





SHP



Marine shipping operations





SOL



Solvent use
DOI: 10.5281/zenodo.16914233
title: Optimized PM2.5 Source Profiles using CMAQ-ISAM and an updated seed profile incorporating California onroad mobile measurements

description: This dataset is a collection of optimized, chemically speciated PM2.5 source profiles for 5 sites in California over the month of January 2016. The sites are listed below:






Site Name



State



AQS Site ID



Latitude



Longitude





Bakersfield



CA



06-029-0014



35.356092



-119.041209





Fresno



CA



06-019-0011



36.785322



-119.774174





Modesto



CA



06-099-0005



37.642165



-120.9942120





Sacramento



CA



06-067-0006



38.613779



-121.368014





Visalia



CA



06-107-2002



36.332179



-119.291228





All profiles used the same nonlinear optimization process as explained in Ivey et al. 2016, (doi.org/10.1007/s11783-016-0866-6) with the addition of two source sectors that incorporate aging of initial emissions into PM2.5. The sensitivity inputs for these profiles are 24-hour averaged CMAQ-ISAM data corresponding to the dates of CSN measurements collected at the five sites. All profiles use chemical speciation network (CSN) measurements collected over January 2016 at the sites in question as the observational component. The site and day-specific CMAQ-ISAM data can be found at https://doi.org/10.5281/zenodo.16914295.

The "seed profile" used in the optimization process is also available in this dataset as "California_SeedProfile.csv" and uses speciated emissions data from Reff et al., (doi.org/10.1021/es802930x) as well as aged source impacts derived from CMAQ-DDM for AG (doi.org/10.1007/s11783-016-0866-6) and observations of organic nitrate and organosulfate molecular weights for BIO (doi.org/10.5194/acp-15-7307-2015). The profiles for on- and non-road diesel and gasoline emissions (ODE, OGA, NDE, and NGA) were updated using California-specific observations for onroad gasoline and diesel PM2.5 emissions accessed with EPA SPECIATE v5.3. The optimized profiles are provided without row or column labels, but this information can be found in the seed profile file. One profile file is uploaded for each day of available CSN observations at each of the five sites.

The optimized profiles are normalized by source (i.e., the sum of all species contributions for one source must equal 1), and the units in the profile are grams of speciated PM2.5/gram of total PM2.5 from the source. The source categories used here are:






Category name



Description of included sources





AG



Agricultural activities and livestock operations





AIR



Aircraft operations





BIO



Biogenics





COA



Coal combustion





DUS



Dust





FOI



Fuel oil combustion





MET



Metals processing





NDE



Non-road diesel combustion





NG



Natural gas combustion





NGA



Non-road gasoline





NRO



Non-road combustion of other fuels





ODE



On-road diesel combustion





OGA



On-road gasoline combustion





ORO



On-road combustion of other fuels





OTH



All other sources





RAL



Rail operations





RWC



Residential wood combustion





SHP



Marine shipping operations





SOL



Solvent use